Morrison Foerster advised Jamieson Laboratories Ltd. and its parent company Jamieson Wellness Inc., McCarthy Tétrault advised Jamieson Wellness, while Cleary Gottlieb and Stikeman Elliott advised DCP...
Jamieson Wellness’ Partnership with DCP Capital
Silver Crest’s Combination with Tims China
Morrison Foerster and Zhong Lun advised Silver Crest Acquisition Corporation on the deal, while Kirkland & Ellis advised Tims China. TH International Limited (Tims China), the...
Hangzhou DAC Biotechnology’s Collaboration and License Agreement with Janssen
Morrison & Foerster LLP advised Hangzhou DAC Biotechnology Co. on the deal. Hangzhou DAC Biotechnology Co., Ltd. (“DAC Biotechnology”) announced its collaboration and license agreement with Janssen...
Tate & Lyle PLC’s Acquisition of Quantum Hi-Tech
Morrison & Foerster advised Tate & Lyle PLC on the deal. LSE-listed Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and...
Tims China’s $1.8 Billion Business Combination with Silver Crest
Kirkland & Ellis advised TH International Limited (Tims China) on the deal while Morrison & Foerster represented Silver Crest Acquisition Corporation. TH International Limited (Tims China),...
Triastek’s Co-Development Agreement with Sperogenix Therapeutics
Morrison & Foerster LLP advised Triastek, Inc. on the deal. Triastek, Inc., a leading pharmaceutical company specializing in 3D printing of drug products, announced its co-development...